Streetbeat News

Analyst Ratings

MESO

William Blair analyst Sami Corwin has downgraded Mesoblast (NASDAQ:MESO) from Outperform to Market Perform.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 3:22 pm

CF

Mizuho analyst Christopher Parkinson maintains a Neutral rating on CF Industries Holdings (NYSE:CF) and raises the price target from $83 to $84.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 04, 2023 | 3:21 pm

ENOV

Baird analyst Jeff Johnson maintains an Outperform rating on Enovis (NYSE:ENOV) and raises the price target from $67 to $70.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 04, 2023 | 3:21 pm

BCRX

Jefferies analyst Maury Raycroft has upgraded BioCryst Pharma (NASDAQ:BCRX) from Hold to Buy and set a price target of $11.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 3:21 pm

CKPT

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Checkpoint Therapeutics (NASDAQ:CKPT) and maintained a price target of $34.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 3:21 pm

AMZN

Mizuho analyst James Lee maintains a 'Buy' rating on Amazon.com (NASDAQ:AMZN) and raises the price target from $160 to $180.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 04, 2023 | 3:21 pm

TEAM

Mizuho analyst Gregg Moskowitz maintains a Buy rating on Atlassian (NASDAQ:TEAM) and raises the price target from $205 to $240.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 04, 2023 | 3:20 pm

PRTA

HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on Prothena Corp (NASDAQ:PRTA) and maintained a $90 price target.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 3:20 pm

ALB

Mizuho analyst Christopher Parkinson maintains a Neutral rating on Albemarle (NYSE:ALB) and raises the price target from $225 to $227.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 04, 2023 | 3:20 pm

TARA

HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on Protara Therapeutics (NASDAQ:TARA) and maintained a price target of $23.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 3:20 pm